Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013
Increase in Naloxone Prescriptions Dispensed in US Retail Pharmacies Since 2013
复制标题
DOI：
10.2105/ajph.2016.303062
复制
发表时间：
2016-04-01
影响因子：
12.7
通讯作者：
Compton, Wilson M.
中科院分区：
文献类型：
--
作者：
Jones, Christopher M.;Lurie, Peter G.;Compton, Wilson M.
纳洛酮的分配，传统上通过以社区为基础的纳洛酮计划，是解决美国处方阿片类药物和海洛因过量死亡流行病的综合战略的组成部分。最近，在门诊环境中，特别是通过零售药店，越来越多地关注纳洛酮处方，但有关这种做法的数据很少。我们发现，2013年第四季度至2015年第二季度，美国零售药店的纳洛酮配药量增加了1170%。这些研究结果表明，在门诊环境中处方纳洛酮补充了传统的以社区为基础的纳洛酮计划。
Distribution of naloxone, traditionally through community-based naloxone programs, is a component of a comprehensive strategy to address the epidemic of prescription opioid and heroin overdose deaths in the United States. Recently, there has been increased focus on naloxone prescription in the outpatient setting, particularly through retail pharmacies, yet data on this practice are sparse. We found an 1170% increase in naloxone dispensing from US retail pharmacies between the fourth quarter of 2013 and the second quarter of 2015. These findings suggest that prescribing naloxone in the outpatient setting complements traditional community-based naloxone programs.